Replies to post #382687 on NorthWest Biotherapeutics Inc (NWBO)

[X Master]

The trial has nothing to do with competition. The trial has to do with testing compatibility.

[Dr Bala]

There have been many posts that state that the MHRA would be the first RA to approve this therapy, followed by the PEI and the EMA in the EU. Many have posted that these have already approved the endpoint changes. The expectation is that the HPFB in Canada and the FDA would follow suit.